The largest database of trusted experimental protocols

Lunawave

Manufactured by Terumo
Sourced in Japan, United States

LUNAWAVE is a laboratory centrifuge designed for general purpose applications. It features a compact and user-friendly design, with a capacity to accommodate various sample tubes and microplates. The centrifuge operates at adjustable speeds and can be programmed to meet specific processing requirements.

Automatically generated - may contain errors

15 protocols using lunawave

1

Ex Vivo OFDI Imaging of Major Coronary Arteries

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three major coronary arteries, including the left anterior descending artery, the circum ex artery, and the right coronary artery with the surrounding fatty tissue, were carefully removed from the autopsy hearts after death for ex vivo OFDI imaging. The surrounding fatty tissue was carefully dissected from each coronary specimen. Before OFDI examination, using a tapered surgical needle, multiple 6-0 proline sutures were carefully inserted into the plaque segment as a reference point for matching between the OFDI and histological images. This method was successfully performed in previous comparative studies that compared histological ndings and IVUS images 6,7 . A 0.014-inch guidewire was advanced to the distal end of each harvested major coronary artery, followed by an OFDI catheter (LUNAWAVE, Terumo Corporation, Tokyo, Japan). OFDI images of the entire vessel were acquired at a pullback rate of 20 mm/s (160 frames/s).
+ Open protocol
+ Expand
2

Intracoronary Optical Coherence Tomography

Check if the same lab product or an alternative is used in the 5 most similar protocols
C7-XR/ILUMIEN OPTIS (St Jude Medical, St Paul, MN) or LUNAWAVE (Terumo, Tokyo, Japan) was used in the present study.
After a Z-offset adjustment, an OCT image catheter was advanced distally to the stent-treated lesion over a 0.014-inch conventional angioplasty guidewire. After the catheter placement, preheated contrast media at 37 °C (Omnipaque 350 Injection; Daiichi Pharmaceutical, Tokyo, Japan) was flushed through the guiding catheter at a rate of 2 to 4 mL/s for ≈3 to 6 seconds using an injector pump (Mark V; Medrad, Warrendale, PA). When a blood-free image was observed, the OCT imaging core was withdrawn at a rate of 20 or 40 mm/s using the stand-alone electronic control of the pullback motor. The OCT images were stored digitally for subsequent analysis.
+ Open protocol
+ Expand
3

Coronary Angiography with Optical Coherence Tomography

Check if the same lab product or an alternative is used in the 5 most similar protocols
After completion of the diagnostic coronary angiography following a careful manual thrombectomy using an aspiration catheter (Thrombuster III®, KANEKA MEDIX, Osaka, Japan), a frequency domain OCT catheter (ILUMIEN and ILUMIEN OPTIS, Abbot Vascular, Santa Clara, California, USA or LUNAWAVE, Terumo, Tokyo, Japan) over a 0.356 mm conventional angioplasty guidewire was advanced distal to the lesion using a 6F guiding catheter. X-ray contrast medium at 37 °C (Omnipaque 350 Injection, Daiichi Sankyo Co, Ltd, Tokyo, Japan) was infused through the guiding catheter at 2–4 ml/sec for approximately 3–6 sec using an injector pump (Mark V; Medrad, Pennsylvania, USA). Then, an OCT imaging probe was retracted using a pullback device. The OCT images were digitally stored and analyzed using ImageJ.
+ Open protocol
+ Expand
4

Optical Coherence Tomography Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
OCT images were acquired using frequency–domain OCT systems: Abbott OCT (ILUMIEN OPTIS; Abbott Vascular, Santa Clara, CA, United States) or Terumo optical frequency–domain imaging system (Lunawave; Terumo Corporation, Tokyo, Japan). The technique of OCT image acquisition has been described elsewhere[8 (link)]. OCT imaging pullbacks were performed automatically by the dedicated devices while injecting the flushing agent, which was either contrast medium or LMWD-40 (Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan), at a flow rate of 3.0-4.5 mL/s via the guiding catheter using an automated power injector. Pullback speed was 18 mm/s with the Abbott OCT system and 20 mm/s with the Terumo optical frequency-domain imaging system.
+ Open protocol
+ Expand
5

Ventricular Fibrillation During Intravascular Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vfib occurrence was individually adjudicated by 2 independent cardiologists by reviewing ECG recordings during OCT/OFDI examinations identified by markings of each OCT/OFDI procedure. After adjudication of Vfib, the type of flushing agent, injection time length, injection flow rate, and injection volume of flushing agent were documented. The Vfib induction trigger such as R on T was also assessed and the length of time after the end of injection of flushing agent was measured. In all cases of Vfib, the time required Santa Clara, CA, USA) or Terumo OFDI (Lunawave®, Terumo Corporation, Tokyo, Japan). The technique of OCT/OFDI image acquisition has been described elsewhere. 1,3 OCT/OFDI pullbacks were performed automatically by the dedicated devices during injection of flushing agent, either contrast medium (iopamidol, Fuji Pharma Co., Ltd., Tokyo, Japan) or low-molecular-weight dextran with Ringer's lactate solution (LMWD) (Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan), at a flow rate of 3-4 mL/s via the guiding catheter using an automated power injector pump (ACIST CVi, Eden Prairie, MN, USA). Pullback speed selection included 18 mm/s with the Abbott OCT system and 20 mm/s with the Terumo OFDI system. Invasive OCT/OFDI examinations were performed by 9 different
+ Open protocol
+ Expand
6

Intravascular Imaging of Atherosclerotic Plaque

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intravascular ultrasound (IVUS) assessments were performed using a commercially available system (Terumo, Tokyo, Boston Scientific, Natick, Massachusetts). A frequency-domain optical coherence tomography (OCT) system (C7-XR OCT Intravascular Imaging System, St Jude Medical, St. Paul, MN) or optical frequency-domain imaging (OFDI) system (LUNAWAVE, Terumo Corp., Tokyo, Japan) was used. The choice of imaging device was made at the operator’s discretion. The quantitative evaluation of intravascular images included the minimal lumen area (MLA), proximal and distal reference (ref) lumen area, lesion length (LL), and minimal stent area (MSA). Heavy calcified plaque was defined as plaque with a cross-sectional calcium arc greater than 180°. Lipid-rich plaque was defined as a lipidic arc greater than 180°. Lipidic plaque on OCT or OFDI images was identified as a signal-poor lipid pool with poorly delineated borders beneath a homogeneous signal-poor band. These were identified on IVUS images as attenuated and echolucent plaques.
+ Open protocol
+ Expand
7

Evaluating Stent Neointimal Formation via OFDI

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 1 month after stent implantation, the animals were euthanized with a lethal dose of sodium pentobarbital (40 mg/kg, IV) after deep sedation with 5% inhaled sevoflurane; the heart was then gently removed (n=6 each) (Figure 1). Subsequently, saline and 10% neutral buffered formalin were immediately infused into the left coronary arteries via a constant perfusion pressure system (120 cm H2O). 16, 17 The harvested heart was then fixed with 10% neutral buffered formalin for 24 h. After the whole-heart sample preparation, we performed the OFDI imaging (LUNAWAVE; Terumo, Tokyo, Japan). We introduced an OFDI catheter (Fast View; Terumo, Tokyo, Japan) into the stented left coronary artery with the introduction of an intracoronary guide-wire, and then performed serial OFDI acquisition, with an automatic pullback rate of 40 mm/s.
+ Open protocol
+ Expand
8

OCT Imaging of Stented Coronary Arteries

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed OCT using one of the following systems: M2 OCT system (Light Lab Imaging, Westford, MA, USA; C7XR Fourier-Domain System (St Jude Medical, St Paul, MN, USA), ILUMIEN (St Jude Medical, St Paul, MN, USA), OPTIS (Abbott Vascular, Santa Clara, CA, USA), and LUNAWAVE (Terumo, Tokyo, Japan). Motorized pullback OCT imaging was performed at a rate of 1.0 mm/s through the stent. Images were acquired at 15.6 frames/s and digitally archived. C7XR, ILUMIEN, and OPTIS system were acquired automatically at a pullback rate of 20 mm/s (100 frames/s) or 36 mm/s (180 frames/s) and that of OFDI at a pullback rate of 20 mm/s (160 frames/s). All images were stored digitally and analyzed offline by the LightLab OCT imaging proprietary software (LightLab Imaging), ILUMIEN/OPTIS software (Abbott Vascular, Santa Clara, CA, USA), or Terumo software. Procedure details using each modality have been previously described [19 (link)].
+ Open protocol
+ Expand
9

Cardiac OCT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
OCT imaging was performed using either C7XR, OPTIS™ (St-Jude Medical, Westford, MA, United States), or Lunawave (Terumo Corp., Tokyo, Japan) Fourier Domain system. Pullbacks were performed by using either a manual or automatic blood flushing at a constant speed ranging from 18–40 mm/s and frame rate that ranged from 100 to 180 fr/s. The collected data were stored in DICOM format and sent to Barts Heart Centre for analysis.
+ Open protocol
+ Expand
10

Optical Coherence Tomography Imaging of Coronary Artery Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
OCT was performed by using either ILUMIEN OPTIS (Abbott Vascular, Santa Clara, CA, USA) or LUNAWAVE (Terumo, Tokyo, Japan). In cases with TIMI flow Grade 0 or 1, aspiration thrombectomy was performed prior to OCT imaging. The OCT catheter was advanced distally to the culprit lesion over a 0.014-inch conventional angioplasty lization, spontaneous coronary artery dissection, stent thrombosis, or coronary artery bypass graft failure were excluded from the study. Patients who had no stent implantation or inadequate OCT before and/or immediately after PCI were also excluded from the analysis.
This study was approved by the institutional review board of Wakayama Medical University Ethics Committee (Reference no. 1920). The requirement for written informed consent was waived because of the retrospective design of the study.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!